"We are stronger together! Based in Grand Rapids, Versiti Blood Center of Michigan (formerly Michigan Blood) combines the strength of blood centers in Michigan, Wisconsin, Indiana, Illinois, and Ohio with state-of-the-art diagnostic laboratories, physician services, and a world-renowned Blood Research Institute. Your blood will always stay local first, but now we will have even more access to rare and unique blood types to help meet the needs of Michigan hospital patients in need. Together, with you, we promise to continue our mission: we are a beacon of hope."

During the past decade, Michigan Blood conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Blood" #1 collaborator was "National Marrow Donor Program" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Blood" are "Healthy" (1 trials) and "Hematologic Neoplasms" (1 trials). Many other conditions were trialed in "Michigan Blood" in a lesser frequency.

Most popular intervention types in "Michigan Blood" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Blood" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Blood". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Michigan Blood, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Blood, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".